Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarra Setrerrahmane

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Acta Pharmaceutica Sinica. B|September 30, 2021
Integrins as attractive targets for cancer therapeuticsMeng Li, Ying Wang, Mengwei Li, et al.
Cancers|September 13, 2025
A Novel Nuclear-Localized Micropeptide, MP60, Promotes Hepatocellular Carcinoma Progression via the Epithelial-Mesenchymal TransitionChencheng Li, Xiu Hong, Sarra Setrerrahmane, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 18, 2024
A multifunctional antibody fusion protein 57103 targeting CD24, IL-4R, and α<sub>v</sub>β<sub>3</sub> for treating cancer and regulating the tumor microenvironmentXiaowei Xu, Jian Li, Sarra Setrerrahmane, et al.
Biochemical Pharmacology|November 15, 2025
ACE1-targeting peptide Acein ameliorates UV-induced skin damage and aging in vivo and in vitro via downregulation of the pro-aging factor CLEC4GTianxiong Zhou, Yunfan Wang, Jiaqi Wang, et al.
International Journal of Molecular Sciences|July 30, 2017
Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced ArthritisJingchao Hao, Xiaodong Wu, Sarra Setrerrahmane, et al.
Molecular Cancer|September 18, 2022
Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinomaMengwei Li, Guangxiang Liu, Xinrong Jin, et al.
Cancer Letters|May 9, 2022
Cancer-related micropeptides encoded by ncRNAs: Promising drug targets and prognostic biomarkersSarra Setrerrahmane, Mengwei Li, Abdelmoumin Zoghbi, et al.
Journal of Hematology & Oncology|March 22, 2018
Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptideErhao Zhang, Jieyi Gu, Jianpeng Xue, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Acta Pharmaceutica Sinica. B|September 30, 2021
Integrins as attractive targets for cancer therapeuticsMeng Li, Ying Wang, Mengwei Li, et al.
Cancers|September 13, 2025
A Novel Nuclear-Localized Micropeptide, MP60, Promotes Hepatocellular Carcinoma Progression via the Epithelial-Mesenchymal TransitionChencheng Li, Xiu Hong, Sarra Setrerrahmane, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 18, 2024
A multifunctional antibody fusion protein 57103 targeting CD24, IL-4R, and α<sub>v</sub>β<sub>3</sub> for treating cancer and regulating the tumor microenvironmentXiaowei Xu, Jian Li, Sarra Setrerrahmane, et al.
Biochemical Pharmacology|November 15, 2025
ACE1-targeting peptide Acein ameliorates UV-induced skin damage and aging in vivo and in vitro via downregulation of the pro-aging factor CLEC4GTianxiong Zhou, Yunfan Wang, Jiaqi Wang, et al.
International Journal of Molecular Sciences|July 30, 2017
Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced ArthritisJingchao Hao, Xiaodong Wu, Sarra Setrerrahmane, et al.
Molecular Cancer|September 18, 2022
Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinomaMengwei Li, Guangxiang Liu, Xinrong Jin, et al.
Cancer Letters|May 9, 2022
Cancer-related micropeptides encoded by ncRNAs: Promising drug targets and prognostic biomarkersSarra Setrerrahmane, Mengwei Li, Abdelmoumin Zoghbi, et al.
Journal of Hematology & Oncology|March 22, 2018
Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptideErhao Zhang, Jieyi Gu, Jianpeng Xue, et al.
Pageof 2